Literature DB >> 12395374

Cyclin A correlates with carcinogenesis and metastasis, and p27(kip1) correlates with lymphatic invasion, in colorectal neoplasms.

Jia-Qing Li1, Hiroshi Miki, Fei Wu, Kousuke Saoo, Mikio Nishioka, Masaki Ohmori, Katsumi Imaida.   

Abstract

Cyclin A binds to CDK2 and plays critical roles when cells proliferate; staining for Ki67 can monitor the proliferation. The cyclin A expression pattern remains unclear in colorectal carcinogenesis and remote metastasis, however, and no one has reported on the association of its expression with key clinicopathologic factors in primary cancer. p27(kip1) protein-an extremely important inhibitor of CDK2-seems unchanged as colorectal cancers metastasize to the lymph nodes, a result contrary to that seen in gastric and prostatic cancers. To clarify the role of cyclin A in multistage colorectal neoplasms, cyclin A, CDK2, and Ki67 were immunohistochemically stained in 22 normal mucosa, 9 hyperplastic polyps, 61 adenomas, 197 primary carcinomas, 21 lymph node metastases, and 10 hepatic metastases. To clarify the alteration of p27(kip1) during lymphatic invasion, p27(kip1) was also stained in 21 primary cancers and paired lymph node foci. Situated in nuclei, cyclin A expression gradually increased from mild through moderate to severe dysplasia in adenomas and from normal tissue through hyperplasia to adenoma to early carcinoma. Expression was significantly decreased in the hepatic metastases and in the primary cancers showing venous invasion, deep infiltration, lymph node metastasis, mucinous type, advanced stage, or short postoperative survival time. Elevated cyclin A not only was linked with elevated CDK2 in primary cancers, but also was associated with increased Ki67 in both adenomas and primary carcinomas. Lymph node metastases lost more p27(kip1) than primary foci and hepatic lesions. Thus, dysregulation of cyclin A and its control mechanisms may contribute to colorectal carcinogenesis; abatement of overexpression of cyclin A is associated with hepatic metastasis and cancerous invasion. Loss of p27(kip1) may promote lymph node metastasis. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395374     DOI: 10.1053/hupa.2002.125774

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  21 in total

1.  The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.

Authors:  Ritu Shekhar; Priyanka Priyanka; Praveen Kumar; Tanushree Ghosh; Md Muntaz Khan; Perumal Nagarajan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

2.  Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma.

Authors:  Jong-Shiaw Jin; Lien-Fu Lin; Jui-Chang Chen; Chia-Chi Huang; Jeng-Horng Sheu; Wenlung Chen; Tang-Yi Tsao; Chih-Wei Hsu
Journal:  Oncol Lett       Date:  2015-09-25       Impact factor: 2.967

3.  Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer.

Authors:  Yuchen Guo; Monica Gabola; Rossano Lattanzio; Conception Paul; Valérie Pinet; Ruizhi Tang; Hulya Turali; Julie Bremond; Ciro Longobardi; Chloé Maurizy; Quentin Da Costa; Pascal Finetti; Florence Boissière-Michot; Benjamin Rivière; Céline Lemmers; Séverine Garnier; François Bertucci; Inti Zlobec; Karim Chebli; Jamal Tazi; Rania Azar; Jean-Marie Blanchard; Peter Sicinski; Emilie Mamessier; Bénédicte Lemmers; Michael Hahne
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

4.  Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.

Authors:  J Bondi; A Husdal; G Bukholm; J M Nesland; A Bakka; I R K Bukholm
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

5.  Unreported intrinsic disorder in proteins: Disorder emergency room.

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2015-04-22

Review 6.  Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.

Authors:  Mitra Zabihi; Ramin Lotfi; Amir-Mohammad Yousefi; Davood Bashash
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-04       Impact factor: 4.553

7.  Cyclin A2, a novel regulator of EMT.

Authors:  Nawal Bendris; Caroline T Cheung; Hon Sing Leong; John D Lewis; Ann F Chambers; Jean Marie Blanchard; Bénédicte Lemmers
Journal:  Cell Mol Life Sci       Date:  2014-05-31       Impact factor: 9.261

8.  Cyclins and cell cycle control in cancer and disease.

Authors:  Mathew C Casimiro; Marco Crosariol; Emanuele Loro; Zhiping Li; Richard G Pestell
Journal:  Genes Cancer       Date:  2012-11

Review 9.  The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.

Authors:  A A P Slesser; P Georgiou; G Brown; S Mudan; R Goldin; P Tekkis
Journal:  Clin Exp Metastasis       Date:  2012-11-23       Impact factor: 5.150

10.  Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K562 cells upon administration with doxorubicin.

Authors:  Xiaohui Wang; Yujun Song; Jinsong Ren; Xiaogang Qu
Journal:  PLoS One       Date:  2009-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.